PPARG modulators for treatment of osteoporosis
N-ARYLYLMETHYLINDAZOLE MODULATORS OF PPARG
PPARG AGONISTIC MEDICINAL COMPOSITIONS
PPARG/SPP1/CD44 signaling pathway in alveolar macrophages: Mechanisms of lipid dysregulation and therapeutic targets in idiopathic pulmonary fibrosis
PPARG INVERSE AGONISTS AND USES THEREOF